Armata Pharmaceuticals, Inc. (ARMP) Tops Q3 EPS by 3c
Tweet
Share
E-mailGet Alerts ARMP Hot Sheet
Join SI Premium – FREE
Armata Pharmaceuticals, Inc. (NYSE: ARMP) reported Q3 EPS of ($0.15), $0.03 better than the analyst estimate of ($0.18).
For earnings history and earnings-related data on Armata Pharmaceuticals, Inc. (ARMP) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Armata gets $2.5M more in DoD funding for bacteriophage drug
- RBC Capital Starts Centene (CNC) at Sector Perform
- Microsoft (MSFT) Reiterated at Hold by Stifel as Chevron Agreement Announced
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
